VEGFA and vitreous hemorrhage: Because DR is considered a microvascular disease, various anti-VEGF approaches have been used clinically to prevent diabetic retinal neurovascular disease, including retinal neovascularization, vitreous hemorrhage, etc. However, anti-VEGF drugs cannot treat vision loss due to retinal ischemia and degeneration.